Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C025984 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid |
15-hydroxy-5,8,11,13-eicosatetraenoic acid affects the activity of KCNA5 protein | affects activity | 18984061
|
C025984 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid |
cinnamyl-3,4-dihydroxycyanocinnamate inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA] | decreases expression|decreases reaction|increases activity|increases chemical synthesis | 18984061
|
C025984 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid |
Nordihydroguaiaretic Acid inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA] | decreases expression|decreases reaction|increases activity|increases chemical synthesis | 18984061
|
C025984 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid |
[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA | decreases expression|increases activity|increases chemical synthesis | 18984061
|
C025984 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid |
[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 protein | decreases expression|increases activity|increases chemical synthesis | 18984061
|
D000638 |
Amiodarone |
Amiodarone results in decreased expression of KCNA5 mRNA | decreases expression | 15520326
|
D000638 |
Amiodarone |
Amiodarone results in decreased expression of KCNA5 mRNA | decreases expression | 8973384 9302343
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of KCNA5 mRNA | affects expression | 16483693
|
D015764 |
Bepridil |
Bepridil results in decreased activity of KCNA5 protein | decreases activity | 11711026
|
C099255 |
cinnamyl-3,4-dihydroxycyanocinnamate |
cinnamyl-3,4-dihydroxycyanocinnamate inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA] | decreases expression|decreases reaction|increases activity|increases chemical synthesis | 18984061
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of KCNA5 mRNA | increases expression | 15793248 15955845
|
D003907 |
Dexamethasone |
Somatostatin inhibits the reaction [Dexamethasone results in increased expression of KCNA5 mRNA] | decreases reaction|increases expression | 15955845
|
D002945 |
Cisplatin |
KCNA5 protein results in increased susceptibility to Cisplatin | increases response to substance | 17428690
|
D004317 |
Doxorubicin |
KCNA5 protein results in increased susceptibility to Doxorubicin | increases response to substance | 17428690
|
C058249 |
ebastine |
ebastine results in decreased activity of KCNA5 protein | decreases activity | 9196279
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of KCNA5 mRNA | increases expression | 18035473
|
D005472 |
Fluorouracil |
KCNA5 protein results in increased susceptibility to Fluorouracil | increases response to substance | 17428690
|
D007654 |
Ketoconazole |
Ketoconazole results in decreased activity of KCNA5 protein | decreases activity | 9694927
|
D009637 |
Nordihydroguaiaretic Acid |
Nordihydroguaiaretic Acid inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA] | decreases expression|decreases reaction|increases activity|increases chemical synthesis | 18984061
|
D010100 |
Oxygen |
ALOX15 protein promotes the reaction [Oxygen deficiency results in decreased activity of KCNA5 protein] | decreases activity|increases reaction | 18984061
|
D010100 |
Oxygen |
cinnamyl-3,4-dihydroxycyanocinnamate inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA] | decreases expression|decreases reaction|increases activity|increases chemical synthesis | 18984061
|
D010100 |
Oxygen |
Nordihydroguaiaretic Acid inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA] | decreases expression|decreases reaction|increases activity|increases chemical synthesis | 18984061
|
D010100 |
Oxygen |
Oxygen deficiency results in decreased activity of KCNA5 protein | decreases activity | 18984061
|
D010100 |
Oxygen |
Oxygen deficiency results in decreased expression of KCNA5 mRNA | decreases expression | 18984061
|
D010100 |
Oxygen |
Oxygen deficiency results in decreased expression of KCNA5 protein | decreases expression | 18984061
|
D010100 |
Oxygen |
[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA | decreases expression|increases activity|increases chemical synthesis | 18984061
|
D010100 |
Oxygen |
[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 protein | decreases expression|increases activity|increases chemical synthesis | 18984061
|
D011188 |
Potassium |
KCNA5 protein results in increased transport of Potassium | increases transport | 17428690
|
D011374 |
Progesterone |
Progesterone results in decreased activity of KCNA5 protein | decreases activity | 18068743
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of KCNA5 mRNA | decreases expression | 18175754
|
D013004 |
Somatostatin |
Somatostatin inhibits the reaction [Dexamethasone results in increased expression of KCNA5 mRNA] | decreases reaction|increases expression | 15955845
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of KCNA5 mRNA | decreases expression | 15590111
|
D016593 |
Terfenadine |
Terfenadine results in decreased activity of KCNA5 protein | decreases activity | 9196279 8772706
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of KCNA5 mRNA | decreases expression | 16120747
|
D014750 |
Vincristine |
KCNA5 protein results in increased susceptibility to Vincristine | increases response to substance | 17428690
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.42 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.72 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.43 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.84 | 12690470 17670903 15814532 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
4.41 | 16759491 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
10.04 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
10.04 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
10.04 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Vincristine |
10.04 | 19825857 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.25 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.42 | 21441931 |
OMIM:607154 |
ALLERGIC RHINITIS |
|
Terfenadine |
5.54 | 16037679 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.29 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.29 | 11748828 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.92 | 20872349 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.69 | 20041841 18218290 18057881 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
3.46 | 17659584 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
3.73 | 16391483 |
MESH:D001281 |
Atrial Fibrillation |
marker/mechanism |
|
| 19698954 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.80 | 19698954 18651412 |
OMIM:612240 |
ATRIAL FIBRILLATION, FAMILIAL, 7 |
marker/mechanism |
|
| |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
8.64 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.64 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.68 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
11.63 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
11.63 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.21 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.13 | 15380490 15665606 15845082 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.69 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
4.64 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
4.64 | 15939500 16322301 15567936 16115903 16264153 11325840 17426702 15994142 18695136 17983394 19526202 18382427 15136595 15634643 16096432 15993339 18628466 15668708 16935488 17369602 16826403 18234424 15692762 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
4.64 | 15136595 16110121 19217205 16595493 16557594 18608205 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Nordihydroguaiaretic Acid |
4.64 | 18418215 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
4.64 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
4.64 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.64 | 16202921 19059307 19189210 19410462 18855134 18984771 11161223 19103187 19115204 17049068 17893378 20859285 21152245 20005174 19084267 18425577 18815881 19487384 19142967 18821012 20135344 21138602 18629630 20065188 19189212 16818667 15668708 19200415 19221464 19066611 15565566 19288272 17261762 17242785 20544844 19244106 19011961 18997820 19155303 17440819 16273361 16873071 18351453 19289846 20390343 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.64 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
11.92 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
11.92 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.84 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.84 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.38 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
6.46 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.46 | 18059187 16023760 16234567 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
6.46 | 17971768 16332177 16799960 17045692 18930000 17088986 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.46 | 16924424 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.99 | 16685392 12023789 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.66 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
10.66 | 18695887 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vincristine |
10.66 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
10.61 | 17066447 18337622 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
10.61 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
10.61 | 16757204 17066447 18986760 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Vincristine |
10.61 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.50 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.30 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.44 | 16278810 17519947 16455267 16364871 17974986 17131338 16952015 16651473 17924179 16731534 16242529 18627295 17007740 16269455 15792986 17351982 15811867 15476868 17382496 16109756 16612575 15505089 17928571 17329180 17308081 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
5.83 | 15710769 19225199 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
5.83 | 17334414 16243910 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.95 | 18974383 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.62 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.05 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
5.94 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.94 | 18772588 15001691 17016597 16510598 17169374 17172411 16340194 17725105 17018589 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
Nordihydroguaiaretic Acid |
5.94 | 15936596 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
3.47 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.47 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.47 | 17695437 18949393 18509181 16391804 18383874 17016601 18802399 17594712 15148649 16524972 16282729 17255274 20501625 17094418 16331619 18448328 16303861 18288408 17401013 14970324 15289873 17454858 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.95 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
2.58 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.58 | 10048152 20055451 15322242 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.66 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.23 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.28 | 12438553 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.66 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.36 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.36 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.57 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
11.64 | 15265979 18218290 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
11.64 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ketoconazole |
11.64 | 18289764 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
11.64 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.64 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
13.21 | 12649298 12231392 19839026 15033597 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
13.21 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
13.21 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
4.70 | 20016425 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.33 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
6.48 | 19703484 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.48 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.77 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
8.74 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.74 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.28 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.28 | 19155303 17893378 20544844 16202921 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.54 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.54 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.03 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
4.66 | 16481741 16785472 17638652 15173087 15464296 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.66 | 15173087 16785472 16337965 16481741 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
7.55 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
7.55 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.16 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.33 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.40 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
11.00 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
11.00 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.82 | 20067830 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
5.09 | 20016425 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.26 | 17150277 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.82 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.47 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
12.54 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
12.54 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
12.54 | 15162350 18337622 15102660 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.18 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.31 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.26 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.39 | 17888722 16244372 18674790 16495754 16244371 18006777 16144979 17875725 16707910 16879835 12587719 14766674 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.26 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.78 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.21 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
8.11 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.11 | 16120746 15340226 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
3.03 | 7520565 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
11.89 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
11.89 | 17606976 15147373 18501091 |
MESH:D006689 |
Hodgkin Disease |
|
Vincristine |
11.89 | 16794504 16135485 15147373 17606976 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 16959395 16354765 8697196 18606429 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
3.75 | 9751232 8137927 |
MESH:D006967 |
Hypersensitivity |
|
Terfenadine |
5.12 | 2570798 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
5.09 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.09 | 18670907 18850075 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Potassium |
5.73 | 19822448 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.38 | 17991464 18020914 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.27 | 15869954 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
15.15 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
15.15 | 17296493 |
MESH:D007249 |
Inflammation |
|
Progesterone |
15.15 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
15.15 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
15.15 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Nordihydroguaiaretic Acid |
5.61 | 18473937 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.19 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 16580747 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
5.01 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
6.19 | 19839026 12649298 18289764 12231392 15190930 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.19 | 15699352 15369732 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.03 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.15 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.15 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.67 | 11231351 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Ketoconazole |
4.59 | 8889330 2166429 1311351 19744259 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Ketoconazole |
4.44 | 11332679 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.03 | 16085563 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
12.77 | 15342952 17567588 |
MESH:D008064 |
Lipidoses |
|
Ketoconazole |
12.77 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
12.77 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
4.85 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.85 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.85 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.85 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
7.14 | 18383874 15113037 16603448 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.14 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.14 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
5.64 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.64 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
8.50 | 11989578 15350150 17391786 |
MESH:D008133 |
Long QT Syndrome |
|
Terfenadine |
8.50 | 8772706 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.29 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.35 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
4.38 | 18339021 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
10.47 | 6189445 17225452 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
10.47 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
10.47 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
10.47 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
10.47 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.47 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Vincristine |
10.47 | 19825857 6189445 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.66 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.37 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.93 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.68 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.44 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.63 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
9.55 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
9.55 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.55 | 16827153 14580682 19196722 11731420 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.42 | 19453300 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
5.06 | 12393984 15577323 11135225 16809738 12883367 16248763 18332650 16432458 12374674 17023156 18176117 18505091 17761969 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
5.06 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.06 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
18.90 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
18.90 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Vincristine |
18.90 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
6.28 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.28 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.38 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.53 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.66 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.41 | 15867202 15744524 16118317 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.77 | 12754197 17974566 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.47 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
6.27 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Vincristine |
6.27 | 17284715 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.91 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.70 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.70 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.47 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
5.13 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
5.13 | 16928823 18600527 18239605 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.87 | 19189210 19200415 19196722 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.36 | 15464296 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.64 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.89 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.09 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
6.92 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.92 | 15555623 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
11.39 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Vincristine |
11.39 | 12837982 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.35 | 16436463 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.01 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
4.98 | 17225452 19769630 15464296 6897625 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.98 | 16525653 17393432 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
5.38 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.38 | 16929163 19003803 16500647 15113037 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.12 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.18 | 15464296 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.03 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
13.50 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
13.50 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.43 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
7.87 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Vincristine |
7.87 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.06 | 11896295 11118676 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.90 | 16868541 15897917 15749863 16729912 16888761 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.90 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Ketoconazole |
1.90 | 17404083 |
MESH:D011471 |
Prostatic Neoplasms |
|
Nordihydroguaiaretic Acid |
1.90 | 18491370 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
1.90 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.90 | 15067354 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.80 | 12490602 12832656 11597910 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.90 | 18722050 18286688 16160472 15538739 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
9.94 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
9.94 | 17922066 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
9.07 | 18379247 11700416 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
9.07 | 17627322 18339021 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 18990726 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Terfenadine |
5.79 | 8201490 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.81 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.87 | 15625365 17203757 16767912 17710206 15675481 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
10.02 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
10.02 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.66 | 17846226 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.95 | 18724381 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.48 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.48 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.21 | 15464296 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.44 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.16 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
10.43 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
10.43 | 19457130 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.19 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
2.67 | 15958060 18396642 17522103 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.67 | 17522103 15786421 16424979 18567086 18396642 19084572 17172411 16951190 17498489 19015929 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
7.07 | 18087811 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
7.07 | 15138204 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
5.41 | 12563064 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Vincristine |
5.74 | 12837982 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.16 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
4.06 | 19225199 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.51 | 17225452 15464296 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
11.62 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
11.62 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.27 | 17909728 16010429 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.73 | 19584973 18020914 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.87 | 16280240 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
10.46 | 17467628 11989578 |
MESH:D016171 |
Torsades de Pointes |
|
Terfenadine |
10.46 | 8256756 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
8.14 | 15464296 12973940 17225452 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.14 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.14 | 16712894 8653321 17572228 |
MESH:D014581 |
Urticaria |
|
Terfenadine |
5.16 | 2565098 2885854 2569995 2568013 2859714 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
9.26 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.26 | 16803524 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.69 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.48 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.47 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.09 | 17638931 17334414 16364871 17678736 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.59 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.12 | 15886252 |